IRF7 promoted the polarization of tumor-associated macrophages (TAMs) to M2 type, inhibited anti-inflammatory factor production, enhanced immune escape of tumor cells, proliferation and migration of breast cancer cells, and thus promoting the development of breast cancer. The gene discussed is IRF7; the disease is breast carcinoma.